TLDR:

• Latticework Capital Management closed LCM Healthcare Fund II with $345 million in total commitments.
• The firm focuses on control investments in founder-led lower middle-market healthcare companies.

Latticework Capital Management, a Dallas-based private equity firm, closed its LCM Healthcare Fund II with total commitments of $345 million, surpassing its $275 million target. The firm, founded in 2015, now has $550 million in assets under management across two funds. The oversubscribed second fund attracted a diverse group of global investors, including leading endowments, family offices, and fund of funds. Latticework specializes in making control equity investments in the healthcare industry, with a focus on lower middle-market companies that are founder-led and seeking a partner to accelerate growth. The firm emphasizes building partnerships with founders and entrepreneurs to drive growth and create value through organic initiatives and acquisitions. With a track record of successful investments, Latticework has completed 11 platform transactions, 120 add-on acquisitions, and more than 130 transactions to support portfolio growth. Recently, a portfolio company formed by Latticework, American Clinical Research Services, announced the acquisition of Elixia, a clinical research network specializing in nephrology, neuroscience, and infectious diseases. Latticework’s portfolio spans various healthcare sectors, including business services, providers, and pharmaceutical services. The firm’s expertise and network in the industry position it to help companies scale and realize long-term value in the healthcare market.